Chapters Transcript Video Contraceptive Care for Adolescents: Pearls, Pitfalls, and Practice Updates So thank you again for that introduction. I'm Doctor Kira Engle. I'm an adolescent medicine fellow, and I'm gonna be presenting this topic with uh Doctor Amanda Bryson, who's assistant professor here. And I wanna kind of get things started with a quote that I really like. So this quote is, Education and access to contraception are an essential part of the teenager's healthcare needs. It's an important part of the work that we do. And so we're really excited to bring this topic and this information to you guys. In terms of disclosures, Doctor Bryson and I do not have any disclosures. Um, the planning peers who invited us for this talk do have some disclosures which are listed here. In terms of our learning objectives, our hope is that attendees will be able to discuss the principles of patient-centered counseling and how they apply to adolescent contraceptive care. They'll be able to compare different contraceptive methods based on their benefits, risks, and contraindications for a range of common adolescent conditions, to be able to develop a plan for initiating and monitoring contraceptive methods in your clinical practice and managing common side effects, and lastly recognize when to refer adolescent patients to a specialist for contraceptive management. We will achieve these objectives by first starting off with a discussion about reproductive autonomy, followed by patient, uh, person-centered contraceptive care, and then we'll do a case-based review of contraceptive methods to really get into the risks, benefits, benefits, and contraindications of the different methods. And then lastly, we'll touch upon when to refer to a specialist. So I'll go ahead and have Doctor Bryson take over. All right. Next slide. Thank you so much, Kira, for that introduction. I really find it important to ground all conversations about contraception and the concept of reproductive autonomy. So reproductive autonomy is defined as having the power to decide about and control matters related to contraceptive use, pregnancy, and childbearing. And this schema on the slide is a published framework on women's reproductive autonomy, which can be applied to adolescents and young adults of all genders. And as illustrated in this schema, reproductive autonomy can be influenced by many factors across socioecological. Levels and how much reproductive autonomy someone has directly influences their ability to control when, if and how they become pregnant and whether they achieve their own reproductive goals and intentions. Next slide. But what I think is missing from this schema is how we, the clinicians, fit in. How clinicians can either enhance or hinder an individual's reproductive autonomy through their clinical practice, research, and advocacy. And so I've put uh the clinician here at the center in this adapted framework ensuring adolescents have confidential time to discuss reproductive health with clinicians using person centered reproductive health outcomes in adolescent focused reproductive health research and advocating for reduced barriers to evidence-based reproductive health care. are all examples of ways clinicians can promote reproductive autonomy in their work. And in the next few slides, we'll dive deeper into how you can provide contraceptive care and counseling to support your adolescent patients' reproductive autonomy in your clinical practice. Next slide. So taking it a step further and thinking about adolescent agency and autonomy, I want to recognize that It's complicated. There's a lot of complexity in considering agency and autonomy when providing contraceptive care to adolescents. Clinicians may have strong feelings about adolescent sexual activity, contraceptive use, or pregnancy that is shaped by personal beliefs, medical education, clinical experiences, or other influences. And in some cases, clinicians may feel a tension when there's a conflict in what a clinician feels is best for their patient and what the patient desires. This might come up when an adolescent who discloses sexual activity expresses their desire to not use contraception or choose to use a less effective method of contraception. Navigating adolescent agency and autonomy can be particularly challenging in primary care pediatrics when clinicians have long-standing relationships with parents who may have desires and goals related to contraceptive use that are different than those of their adolescent child. Child and the pediatrician is positioned between both of those folks to make a decision around contraceptive care and the job of the pediatrician in that moment is to prioritize and promote adolescent and agency and autonomy in those decisions. Additionally, clinicians caring for adolescents must be adept in adjusting their clinical practice based on the cognitive development and maturation of their adolescent patient. So the bottom line is this can be really complicated even for the most experienced of pediatricians. Next line. But despite these tensions and complexity, prioritizing adolescent autonomy when providing healthcare is paramount. Adolescent agency and reproductive healthcare is codified in California state law, which allows for minors to consent to care related to pregnancy prevention, including all forms of contraception except sterilization. In further human rights frameworks established by the United Nations, Underscore the importance of adolescent reproductive autonomy and have asserted that adolescents can make autonomous informed decisions on their reproductive health and that adolescent reproductive health services must be consented to voluntarily free from pressure, violence, or coercion. Next slide. So with that grounding, we'll transition into person-centered contraceptive care principles that you can use in your clinical practice to promote adolescent reproductive autonomy when providing contraceptive care. Next slide. This is a screenshot of a table from a review article that myself and colleagues recently published in Current Opinion in Pediatrics that reviews some key principles for person-centered contraceptive care. And I'll walk through most of these one by one and give some examples of what this looks like in clinical practice. Next slide. So the first one here is do not assume adolescent wishes to avoid pregnancy. I think this goes back to um what I was mentioning previously and thinking about reproductive autonomy and. I think that a lot of times there could be an assumption that just because someone is an adolescent or a younger person, their goal or desire is to avoid pregnancy, but it's really important to understand that adolescents can have a range of desires and intentions and thoughts related to pregnancy that can range from wanting to avoid it to desiring a pregnancy and often somewhere in between with ambivalence towards pregnancy. And it's important to hear from the adolescent themselves what their goals and wishes are related to pregnancy instead of coming in with our own preconceived notions as clinicians. And then next, it's really important to ask permission to talk about contraception before starting the conversation. And there's many ways to do this, but I really like an adapted version of the self-identified need for contraception screening question or the sync. This was initially designed to be part of the rooming process for something like a family um family medicine office or OBGYN where this would be kind of part of the standard intake process, but I think this can really be adapted to come up casually in conversation as well. So I say something like I ask everyone about their reproductive health needs. Do you wanna talk about contraception or pregnancy prevention during your visit today? This opens the door to have the conversation and leaves it in the court of the adolescent to decide whether they want to have that conversation. And this can be asked to people of all genders who might want information about contraception or pregnancy prevention. Next slide. The next 4 listed in this table here um are related to contraceptive counseling. So the first, listen to, value, and address adolescents' preferences, goals and concerns around contraception. Present methods that best align with the adolescent's preferences first, accept ambivalence and affirm the adolescent's autonomy. And support and normalize the contraceptive journey which includes trying, discontinuing, switching or not trying any method and I like to operationalize these principles using the pick one approach which I'll go through each of these components. The first is asking past history with contraception. What has your patient used before? What have they liked about it? What did they not like about it? That can really help get the conversation moving in the right direction based on their own real experiences with contraception. The next is ask important factors in the methods. What are things that they prioritize, um, in choosing a contraception method? This might be things like wanting to also treat their acne or wanting to have a predictive bleeding pattern or not wanting to need to do something every single day like taking a pill. And this helps tailor your conversation to what matters to your adolescent patient most. The next is explore contraindications to specific methods which Doctor Ingle will review in detail in the cases, but generally we want to think about which options are safer for adolescents versus might have some risks or contraindications associated with them and bring that into our counseling. The next is share knowledge about methods again starting with those methods that are most aligned with the adolescent's preferences first and asking for permission if you're going to discuss methods that don't align with their preferences as well as give a reasoning why you think it's worth still discussing this method because you think there might be a different benefit that hadn't been considered previously. Then you want to explore obstacles decision making, what other information might they need to make a decision, who else might they want to involve in the decision to start a contraceptive. And then asked if they're ready to make a decision now. We really want to balance having the ability to start a same day contraceptive method with giving people enough time to consider their options and making a decision that feels right to them. And then the last is respect the experience with the method and this kind of comes to if you're doing follow up care and people are experiencing side effects or symptoms working with the adolescent on that contraceptive journey to to decide whether it's, you know, time to switch the method, stop the method, try something new and. And continuing to to believe in what the adolescent is telling you about their experience with the contraception. Next slide, please. And the last thing here that I want to review in this table is using adolescent friendly decision aids. There are a couple of key considerations here. The first is using different decision aids for different conversations and avoiding an over reliance on the tiered effectiveness charts. So the tiered effectiveness charts, I'm sure many of you have seen them. They are the, the charts that uh review contraceptive methods in order of efficacy where you would review the most effective methods first and then uh the least effective methods going down the line. And this used to be the more recommended or gold standard way to discuss contraception. However, in more recent years there's been growing critiques of that method that um it oversimplifies or over relies on efficacy related to the contraception as the driver of. Decision making whereas we know that people think of many factors that go into what contraceptive method is best for them and so it's really important for us to again root our conversation and what's important to the adolescent it might be effectiveness, but it might be another factor and then I've listed some of the resources that I tend to use here in this slide, but there's, you know, many available online. Next slide. And just to give you a visual, this is one of the um contraceptive decision aids I like to use from Reproductive Health Access Project. This is just a screenshot of part of it. It's a larger chart that has all of the methods available, and this one I like to use when an adolescent. Doesn't have a strong preference and we go through each thing one by one and kind of identify ones that are in line with their preferences, cross out ones that they don't like or are contraindicated, and use these columns to compare and contrast to find a method that's right for them. Next slide. And then this is another option that just takes a different approach. This is birth control, what's important to you from power to decide or be on the pill. There's many different versions of this chart that you can orient the conversation based on an important factor for the contraceptive method, and this example just goes through how you might structure a conversation if having a predictive bleeding pattern or how the birth control might change their period is the thing that's most important to the adolescent. Next slide. OK. With that background, I'm going to pass it off to Doctor Engle to go through the contraceptive methods. Great. Thank you. So, let's get started with the discussion about different contraceptive methods with a case. So we have SB. She is a 14 year old female who presents to your office for an annual exam. During her head assessment, she discloses that she is sexually active, and she would like to start a birth control method to prevent pregnancy. She has no significant past medical history or family history. She is interested in a short-acting method and wants a predictive bleeding pattern. And she also discloses that she last had unprotected sex 2 days ago. So the first thing I wanna talk about and the big question would come to my mind first is what are the different methods that have a predictive bleeding pattern? And so these methods are gonna be the ones that have estrogen and these collectively all these methods are called combined hormonal contraceptives or CHC and these methods include combined oral contraceptive pills, the patch, and the ring. I think it can be sometimes overwhelming to think about all the different methods. So kind of just to recognize the pattern, almost all the methods will use ethanol estradiol, which is a synthetic form of estrogen, as their estrogen. There's only one, pill on the market right now that doesn't use ethanol estradiol. And so the main way in which these methods actually differ is by the method of administration as well as the specific progestin used. So I wanna go a little bit more in depth into the different types of um administration. So with the first one, there's the vaginal ring. I describe it to patients as like a stiff hair tie. Um, it has hormone in it and how patients use it is they click pinch it and they put it into the vagina and let it go and it can get into place and then to remove it they put their finger up, hook around and pull it out. A lot of clinics have these plastic demos that the company will share. The common one that's been around for longer is the NuvaRing which contains the progestin etonogesterol and ethanol estradiol. It is placed into the vagina for 3 weeks and then you remove it for 1 ring-free week. That's gonna be a common pattern you're gonna see in all these methods. So it's 3 weeks with the method. One week off the method. There's also a newer ring that recently came onto the market, Anovera, which uses the progestin progesterone acetate in addition to ethanol estradiol. The big difference between the NuvaRing and the Anovera is the Anovera can be reused after each month, so you could continue using it up to 1 year, putting it in for those 3 weeks and then taking it out for your ring-free week. The other method that I wanna highlight is the patch. So the patch is a sticky adhesive that can be put in different parts of the body. I highlight a few places here that are commonly used cause they're more discrete, but it really can be put anywhere except for the breasts. And so usually what people do is they place it on. They then remove it after one week and they'll oftentimes just alternate sides. So they may do the left arm one week, the right arm the next week, followed by again the left arm. And then you have one week where you have Of a patch-free week. So again, 3 weeks with patches, 1 week without patches. The common brands are Xulane and Dafamine which have 35 mcg ethanol estradiol and use the progestin norogestromin. And then there's also Torala which has 30 mcg ethanol estradiol and uses the progestin levoniestrel. And then last there are the birth control pills. As opposed to the other methods, there are a lot more different formulations of the combined hormonal contraceptive pills. Um, I think there's last looked about 20. And so there's a few more details that you have to think about. The first thing. You want to think about is what dose of ethanol estradiol you want to use. The default I usually go with is 30. However, there also is 35 mcg available as well as 20 and even 10. And I'll go into some circumstances in which you might want to use some of the other ones, but I think a good default is 30. The next thing to consider is your progestin choice. I think in most circumstances, um, this is less important than some of the other details, but I will go into a little bit more about when I would choose one progestin over the other in the next slide. And then it's also important to think about the dosing regimen. So the standard dosing regimen is to have 21 active pills or 3 weeks of active pills and then 1 week or 7 days of inactive pills, which is shown here in the picture I have. But there are newer newer formulas. that have come out that have 24 active pills and 4 inactive pills, which can for some people be easier to remember. And there's also extended cycle formulations in which you would have 3 months of pills followed by 1 week off. And the pill pack itself would have that all planned out for you. And then lastly, something to consider is cost. Some of the newer birth control methods may not be covered by insurance, and so that's just another factor to consider for your patients. And so I wanna just touch briefly upon when I would choose a different dose of ethanol estradiol or I would consider changing the progestin that I'm prescribing. So here are some common side effects that patients may report or concerns they may have. So the first is breakthrough bleeding. So if a patient comes in complaining of breakthrough bleeding with their current dose, what you could do is you could increase the ethanol estradiol dose, so go to from either 20 to 30 or 30 to 35. And then another thing you could do is change the progestin to one that, uh, such as norithendrone, which has more activity at the estrogen receptor. So the progestins really are a category of hormones and they have different effects at different receptors and so you could just choose one that has more of an effect at that receptor. Um, other things that people may talk about is having breast tenderness or nausea. This usually improves within the first couple of weeks, but for patients who aren't able to tolerate it but still wanna try the pill, you could switch to a pill that has a lower dose of ethanol estradiol. If they're complaining of headaches, you could decrease the ethanol estradiol dose as well, um, and also the progestin dose or try a different one. If they're having acne or hirsutism, that would be an indication to consider increasing the ethanol. Esradiol and switching to a progestin with less angiogenicity such as risperinone. And then if they're having cadamial symptoms or cyclical symptoms, you'd want to consider switching to continuous cycline or extended cycle formulations like the one I referred to before where there is 3 months on and then 1 week off. So after further discussion with SB she decides that she wants to try oral contraceptive pills and so your next question is when do I start them? And so I wanna highlight here this incredible resource available both as a website and an app called the US Selected Practice Recommendations for contraceptive use, most recently updated in 2024. I usually refer to them as the SBR. And you can see here they provide guidance based on each method about when to initiate it and how to manage um any sort of complications that may arise. It's really helpful and easy to use. So for SB if let's say you already download the app, you'll go into the app and you would click on combined hormonal contraceptives and you see this incredible graph. Which shows you here that for combined hormonal contraceptives, you can start them anytime as long as you're reasonably certain that the patient is not pregnant. And so the next question you have is how can I be reasonably certain that my patient is not pregnant? What do I need to do? And so there's certain criteria that are outlined in the SBR which talk about how to make sure your patients aren't reasonably pregnant. And so basically you wanna make sure that they meet at least one of the following criteria. It's been less than 57 days after the start of the normal menses. They have not had sexual intercourse since the start of their last normal menses. They have been correctly and consistently using a reliable method of contraception. It's been less than 7 days after a spontaneous or induced abortion or they are postpartum or breastfeeding. SB does not meet any of these criteria criteria, so we cannot actually be certain that she is not pregnant. And this is something that's actually addressed in the SVR guidelines where they say even if you are uncertain of pregnancy, in almost all cases, the benefits of starting a method now likely exceed any risk, with the exception being an IUD. So if you're going to place an IUD, that is the time when you want to delay starting that method until you had become certain that the patient was not pregnant. But for this case, um, we, the benefit of starting the method now does outweigh the risk. Our recommendation would be to have her do a pregnancy test in 2 to 4 weeks, which she could do either at home, what I usually recommend in my practice or who come back into the office for, but I would still provide her with the 1 year of birth control prescription, so I wouldn't hold that prescription based on her needing to complete the test. That's the current standard of care. So You decide you're gonna do the birth control pill, you're gonna start it now. You'd already did a pregnancy test in office which was negative and you're gonna recommend another one. But what are the tests you need to do? Is that enough? Can we start it today? Do we need to do any other testing or monitoring? And so this is another place where the SBR guidelines provide uh recommendations, and they say for combined hormonal contraceptive, the only examination or test needed before initiation is to measure a blood pressure. So you measure SB's blood pressure and it's 100/62, so you feel comfortable prescribing the birth control. And so what are other things you should think about? We kind of thought about the birth control, but is there anything else that should be addressed when you are providing birth control for a patient? And the answer is yes. I always think of emergency contraception, both for now as well as for future use. So for SB she had sex without a condom two days ago. So she is someone who's going to need it now. And there are a couple different options which I kind of want to stop and pause and just go through. So there's in the first column levonogesterol or Plan B. Then the second column we have ulepristal acetate or ELA, and in the last column we have the copper IUD or the levonogesterol 52 mg IUD which has now been approved off-label for use for emergency contraception. And there are a lot of key differences to think about and discuss with patients between these different methods. Timing wise, they all can be used up to 5 days after sex without a condom. In terms of access, Plan B is the easiest to access because it's available over the counter, can be purchased at a pharmacy. Um, next there is Ella that requires a prescription. And then last, there's the copper IUD or the levonogesterol 52 mg IUD which will require a procedure. They also have varying degrees of effectiveness based on patient's weight and BMI. So Plan B has decreased effectiveness if a patient is greater than 165 pounds or has a BMI greater than 25, with a strong recommendation not to use it if they have a BMI over 30. Ella, on the other hand, Ella's effectiveness starts decreasing after 195 pounds or a BMI of 30 with um recommendation not to use it after BMI or might not have effectiveness after BMI of 35. And then lastly, the copper IUD and levonodestrel 52 mg IUD are highly effective at all BMIs. Another thing that's really important to consider, particularly during these visits, we're gonna be prescribing a birth control method, is how these methods may interfere with hormonal contraception. So Plan B, um, which is a progestin, would not interfere with the birth control method. It can be done, taken immediately, and the hormonal contraceptive method could be started immediately. Ella or liprostol acetate, which is a selective progesterone receptor inhibitor, does interfere with hormonal contraception. So if it were to be taken today, you'd have to delay starting a hormonal contraceptive for 5 days. So that's just something important to consider. Talking to SB and reviewing her chart, you see that she has a BMI of 26, um, and so based on shared decision making, she would like to try to take Ella. To prevent pregnancy after having sex without a condom two days ago. And so, what is the plan? So, you wrap up your visit. The plan will be that SP will take Ella today, and then in 5 days or day 6, she will start the combined hormonal contraceptive pill. You've instructed her based on the SPR guidelines that she needs to use condoms or practice abstinence for the 7 days after taking it. Um, if she does not have a withdrawal bleed within 3 weeks after taking the emergency contraception, you're gonna recommend she take a pregnancy test. Um, and she's happy and she leaves your office. Um, but it's a particularly heavy birth control day, so you have another patient that comes in, JD. JD is a 16 year old female, and she comes in cause she wants to discuss birth control. She has a history of migraines with aura. She says that she is interested in pills and she's not sexually active yet, but she is planning to become sexually active soon with her boyfriend. And so before we continue, I wanna highlight another incredible resource from the CDC. It actually happens to be in the same app as the SBR guidelines. So this is the US or the US medical eligibility criteria for contraceptive use. And so this is a. Set of criteria that were also updated in 2024 that provides guidance on the use of different contraceptive methods based on different conditions or medical characteristics that patients may have. And it's really nice because it's organized both by condition and by method. And so these recommendations are categorized, which is methods for each condition are categorized into 4 different categories. So the first, if a method receives a category 1, that means that it's a condition for which there is no restriction for the use of the contraceptive method that you are looking at. If it's a category 2, Uh, it's a condition which the advantages of using the method generally outweigh outweigh the theoretical or proven risks. Category 3, it's a condition where the theoretical or proven risks usually outweigh the advantages of using the method, so it may not be recommended. And then 4, it's a condition that represents an unacceptable health risk if um the contraceptive method is used. Um, I wanna highlight here that these are meant to be tools and not rules. So it's still may be indicated based on discussion with your patient or a specialty provider to prescribe a method that's a category 3 or 4 for a patient's condition. Um, it's really based on your clinical decision making. And clinical decision making is particularly important because also these categories don't account for overlapping risks. So you may have a patient that has both migraines and elevated blood pressure, and unfortunately the app does not account for both these risks together and so you kind of have to consider, uh, the recommendations for each together. And so I want to just quickly highlight what conditions or just a few of the conditions that are covered in the mix. So there's migraines, especially with possible aura, hypertension, which I've already talked about. There is cardiac disease, liver disease, lupus, sickle cell, organ transplant, and then um interactions between anticonvulsants, um, and other common medications. So thinking back to our patients, patient JD, we look up the MC guidelines and look over here where she has headaches with aura. And so she wants to take pills and combined hormonal contraceptives are category 4, so they would not be recommended. Um, and talking to her, she does not want to try those methods based on the risk that you discussed. But she would like to try the progesterone-only pills, which are referred to as POP, which are also a category one for migraines with aura. And so she wants to learn more about the progesterone-only pills and talk about what her options might be to try that. And there are a lot, and so I kinda wanna do a quick review of what the different progesterone-only pills are because they are not all the same. And I kinda wanna start with a little bit of history as well. So the first progesterone-only pill that came to market was the mini pill, which has the progestin northendrone. It has 28 active pills, so there's no weak. Off like you saw with the other pills. And the window for taking the pills is very small. So this is one of the few times in which I tell a patient it's really important they set an alarm. Because if you take the pill even 3 hours late, then you will need a backup method. Um, so that can be really challenging for some patients and important to consider. Because of this challenge, there have been newer birth control methods that have come to market or progesterone-only pills. Specifically Celand. Which uses a different progestin, uses risperinone and because of the different activity of risperinone, they're able to do a pill formulation that has 24 active pills and then 4 inactive pills. It also, in addition to having these inactive pills, also has a little bit more of a wiggle room in terms of taking it. So you wouldn't be considered late on the pill unless you missed it by 24 hours. That can be easier for a lot of patients. However, Slint is a newer product and so sometimes insurance isn't always covering it. Another new New development in the progesterone-only pill category is the availability of the O pill, which uses the progestin norgestrel, and that's now available over the counter so it can be purchased at the store or online and can be a great option for patients who don't want to use their insurance and don't have uh other options. And to just kind of summarize these differences that I've highlighted in kind of uh chart form, you can see here in the first column there's norithentrone, the mini pill, and the Norgestrol, the O pill. You see here that there's 28 active pills. You've considered to be missed a pill if it's been 3 or more hours and you would need a backup method of contraception for 2 days after you miss a pill, which is also different from the risperonone progesterone-only pill or progestin-only pill. Um, one advantage is that the nogesterol is available, which is the O pill is available over the counter, um, and the special consideration for this method is the fact that the timing is so strict. For risperonone, like I already talked about, it has the 24 active pills and 4 placebo pills. Um, you have more wiggle room, so the missed pill period would be more than 24 hours. You need to use a backup method for 7 days if you were to miss multiple pills. Um, but it has this more forgiving dosing window which can be better for some patients. Also, it's important to consider there is this risk of hyperkalemia which is relevant really just for certain, um, medical conditions for some patients and are also talked about in the MC. And so with the updated SBR guidelines, they've now come out with these really helpful algorithms to think about the management of missed pills in these two different circumstances. So you can refer patients to these or review them with patients yourself, um, and it can be a really helpful resource. So you've decided now um after talking to JD that she wants to do the risperone, progesterone-only pill, progestin-only pill. And so you next wanna see is there any reason why you would need to delay starting it? And the answer is no. You feel reasonably certain that she is not pregnant, but you also do a pregnancy test in clinic which is negative. And then you also wanna check and see if there's any examination or test needed before initiation, which there is none. And lastly, you can review how long or what type of um backup method may be needed. So because it's been more than 1 day since her period, you counsel her to either abstain from sexual intercourse or use a backup method such as condoms for 7 days. And here's just a review of that plan. Um, like I said, I also always like to provide emergency contraception whenever I'm prescribing birth control, either for now or for future use, particularly during that seven-day period when they're not going to be protected by the method, so that if they were to have sex without a condom, they could protect themselves and still prevent pregnancy. So you go over that plan and you're feeling really confident about it. And JD leaves happy. But 6 months later, she comes back and she tells you that she's tired of taking a pill every day and she really wants to try a different method. She's been thinking a lot about it. She's been looking online, and she's most interested in the shot, the implant, or the IUD and she wants to discuss with you more and kind of get your input. And so I wanted to do a comparison of these methods, but I first kind of want to stop because I think sometimes it can get overwhelming thinking about IUDs with the shot, and the implant is pretty straightforward because there's really just one of each available. But for the IUD there's been a lot that have come on the market. And so I want to kind of Briefly highlight those differences just so you can provide more um extensive counseling for patients. So really there's 5 IUDs currently available. There's one, the ParaGard in the far right column, which is copper, so there's no, no hormones. And there's 4 currently available that do have hormones. You can see here, which I why I love this table, it shows you when they kind of came onto the market and the differences. So one of the main differences. is the total amount of hormone they have. So both the Mirena and the Liletta have 52 mg of levonogestrel, whereas the Kyla and the Skyla, sorry, Kylina and Skyla have um less. So the Skyla has 13.5 mg of Linogestrel and the Kylina has 19.5 because they have less of the hormone, they um are only Effective for up to 5 years for the Kyleena and then 3 years for the Skyla. Both the Mirena and the Lileta have recently been approved for use for up to 8 years, which is a really big, um, and exciting change. And then over on the Farcom for the copper IUD, the ParaGard, it's been approved now for use up to 12 years. It's been considered acceptable to use it for up to 12 years. Another important difference between these methods is the change in bleeding. So while the more hormone that the IUD has, the more likely your period is to, to go away. You can still have some breakthrough bleeding with them, and you're more likely to see the breakthrough bleeding with the Skyla and the Kylina. Um, and this is very different from the ParaGard IUD where you're likely to have heavier periods, um, and then they will most likely last longer and you'll have more cramps. Another notable difference between these methods is that the Mirena, the Liletta, and the ParaGard, um, can now be used for emergency contraception. They all have similar levels of um cumulative efficacy too. So then going back to the different methods that JD wants to know about and kind of putting them all together to kind of compare, I've consolidated all those, all the hormonal IUDs into a column here on the left, um, highlighting the different duration based on the amount of hormone they contain. Then I have the copper IUD, um, followed by the implant, and then the Depo shot. So important to highlight different in the difference in duration. So the hormonal IUD which I already highlighted, 3 to 8 years, copper IUD 12, implant is now 5 years, which is in a recent update, and the Depo shot is 13 weeks. Um, because the Depo shot you have to keep coming back to those appointments for is found to be less efficacious with typical use. Another important difference that I've already kind of gone into with the IUDs is the bleeding patterns. Like I already said with the hormonal IUDs, the bleeding is likely to decrease, and particularly with the Liletta and Mirena. A lot of patients have amenorrhea. With the copper IUD you have increased bleeding and cramping. The implant is much more unpredictable with the bleeding pattern, and I'll talk about that a little bit more in the next couple of slides. And then with the Depo shot, the bleeding is very irregular but tends to, to decrease over time with continued use. And in terms of advantages, the hormonal IUDs are great for menstrual suppression, and then the Mirena and Liletta can be used for emergency contraception. The copper IUD's biggest advantage is that it's hormone-free, so it's a great option for patients that can't use hormone or who really prioritize not having any hormones. It can also be used for hormonal contra or emergency contraceptive contraception. And then the implant is also highly effective, low maintenance, um, it can be less intimidating for having the insertion done. And then for the Depo shot, this is a recent, um, changes that they've now come out with a way for patients to self-administer it subcutaneously. So they've changed the formulation so that, uh, it's the same formulation but it changed the amount and administration so it could be self-administered at home just to reduce the obstacles to getting it on time. Um, and some of the drawbacks for IUDs are gonna be that the insertion can be uncomfortable. For the copper ID specifically, it can, you can have heavy and more painful periods. So it's gonna be really hard if you, if a patient already has painful periods, then they become more painful with the implant. The most common reason to have it removed is, um, People being upset about the, the bleeding and then with the Depo there are, there's increasing concerns about weight gain, particularly with people who have an elevated BMI as well as effects on bone mineral density which are reversible and usually peak at about 2 years. And then also, um, as was highlighted in the SPR guidelines, there's been um increasing evidence that of the progesterone-only methods there's an increased risk of a blood clot with the Depo shot compared to the other methods. And so after talking to JD about all these different options, she tells you that she would like to get the implant. And so I think in some of our practices it's something we can schedule and do in clinic, um, or maybe something that we're referring to, but whether you're referring for the implant to be placed or doing it yourself, we can all counsel and provide guidance and information to our patients. So I wanna highlight what kind of counseling I'd recommend for a patient that's gonna have an implant inserted either by you or by someone else. The most important thing I talk about is that the bleeding pattern will change. How I tend to phrase it to patients is I say 1/3 of patients will have their period go away, 1/3 of patients will have breakthrough bleeding, um, 1/3 of patients will have more frequent bleeding, um, than their period and may be prolonged. It's important that patients know that this is not bad for their health. There's nothing harmful about it. It can just be annoying for some patients. It's also important to counsel patients that it may change. So those first up to even 6 months, you're likely to see a lot of change in the bleeding pattern. So there's a chance that it could improve after those 6 months. And how I like to talk about this more objectively is I say, you know, the implant is one of the most effective contraceptives that we have, but the trade-off is that your bleeding may become unpredictable. And so you provide this um information and counseling to JD. She has her implant inserted, and you haven't seen her for a while, so you're hoping things are going well. But 4 months later, you see her back on your schedule. She returns and she tells you that she's had 2 months of spotting, and she's wondering if she is OK. Um, on further discussion of her overall health and, and what's been going on, she lets you know that she recently had a new sex partner 3 weeks ago and that they did not use condoms. And so the first thing I like to kind of address in these circumstances is to understand whether or not the patient wants to keep the implant. Um, there's increasing evidence and um understanding that patients often feel coerced or forced to keep Their method, even if they feel like the side effects they're experiencing are unacceptable. I think it's just hard not to feel pressure and so there's really been a big movement to make sure patients know that if they want to have the implant removed, they can have it removed whenever they want. Um, and so it's important to explore that with your patients. So either her options would be to have it removed today or if you're gonna refer out for the removal, we refer out for the removal, or you can ask if she would like to continue to use it. And if she does wanna use it, and it's an opportunity to explore, are these, knowing that these side effects and these bleeding irregularities are not harmful to her health, is that something that she's OK with or is it something she would like to try and treat? Um, and I wanna kind of pause here and acknowledge that I think this is a time period in this care in which this may be something that you would like to refer on to a specialist for either pediatric and adolescent gynecology or adolescent medicine. Or it may be something that you would choose to um address with as, as part of your practice. The things I think about as common reasons when I would refer to pediatric and adolescent gynecology or adolescent medicine would be If the diagnosis is uncertain about a cause of some sort of side effect, if the bleeding from a method is severe or refractory or the bleeding, um, if you're using a method to treat bleeding, the vaginal bleeding is just continuing and you and feels like it's not improving. If you have a concern for some sort of structural disease or if it's outside your comfort level. But in the scenario that you did decide to help manage JD's bleeding irregularities, there are some really helpful algorithms on SBR um app. And they have this really wonderful algorithm. I kind of have it here down below what you would do for implant users. It's an algorithm that addresses the breakthrough bleeding that can occur really with any method and goes into different options. But I also wanna highlight and walk you through that really what you should start to do first is after figuring out whether or not the patient wants to continue the method, make sure you're considering all other possibilities for the bleeding besides just her birth control method. So particularly for our patient, it'd be important to consider whether or not she has an STI since she did have sex without a condom. Um, recently, you also could consider pregnancy. Um, you also could consider any sort of new medication interacting with her method, thyroid disease, or some sort of uterine pathology. Um, and so you might wanna consider testing, um, and kind of getting more history about those things. But once you've kind of decided that you have a good understanding and maybe feel more reassured it most likely is due to the birth control method, that would be an opportunity to discuss different treatment options and you'd be down here in this lower part of the algorithm. And so I'm just gonna kind of blow up that lower part of the algorithm to talk about the different options for patients who want to keep their implant but wants to try a treatment for bleeding irregularities associated with the implant. So there's really kind of two categories of options. The first are treatments that might improve the bleeding irregularities during treatment use. But after you stop the treatment, likely the breakthrough bleeding may come back. I think about These options during the 1st 3 to 6 months that a patient's using the implant. Because I think there's a chance that after they say they use this treatment for 6 months, the bleeding may um settle and they may not have any bleeding. So this could be an option to consider at that time point. The two options are hormonal treatment with either a combined oral contraceptive that contains 20 to 30 mcg of ethanol estradiol or using even just estrogen alone. Another option would be transyamic acid for 5 days. And if you were using the hormonal treatment, you could even have them use this for multiple months and then have them stop it once they've gotten out of that 1st 6 months of the implant and just see where their bleeding is at. Another set of treatment options um to consider are ones that are more likely to stop the bleeding and have it not persist after they stop the treatment. There's two different options in this category, so one would be to do an NSAID like ibuprofen for 5 to 7 days, and then another option would be to do a selective estrogen receptor modulator like tamoxifen for 5 to 7 days, and these can be repeated a few times, um, and so if, if she's still having bleeding, you could try again and have her come back. And so to kind of summarize our plan, so for JD you just have to do STI testing to rule out um an infection as the cause of her bleeding, but feel otherwise reassured by her history that this is mostly due, most likely due to the implant. She would like to keep it. I would like to try a method that would treat her breakthrough bleeding even after she stopped. Dropped it, so she selected NSAIDs, which she will try for 5 days. And because this is a practice scenario, um, in this case it works completely and she's super happy and, and goes on with her life. Um, and so that is the end of that, uh, the cases, and I just wanna thank you for listening and open up the floor for questions. Created by